메뉴 건너뛰기




Volumn 389, Issue 10084, 2017, Pages 2105-2116

Erratum: Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial (The Lancet (2017) 389(10084) (2105–2116), (S0140673617306384), (10.1016/S0140-6736(17)30638-4));Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial

(455)  Shakur, Haleema a   Roberts, Ian a   Fawole, Bukola a   Chaudhri, Rizwana a   El Sheikh, Mohamed a   Akintan, Adesina a   Qureshi, Zahida a   Kidanto, Hussein a   Vwalika, Bellington a   Abdulkadir, Abdulfetah a   Etuk, Saturday a   Noor, Shehla a   Asonganyi, Etienne a   Alfirevic, Zarko a   Beaumont, Danielle a   Ronsmans, Carine a   Arulkumaran, Sabaratnam a   Grant, Adrian a   Afsana, Kaosar a   Gülmezoglu, Metin a   more..

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

EID: 85018171360     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(17)31220-5     Document Type: Erratum
Times cited : (1025)

References (25)
  • 3
  • 4
    • 33748957178 scopus 로고    scopus 로고
    • Maternal mortality: who, when, where, and why
    • Ronsmans, C, Graham, WJ, LMSSS Group. Maternal mortality: who, when, where, and why. Lancet 368 (2006), 1189–1200.
    • (2006) Lancet , vol.368 , pp. 1189-1200
    • Ronsmans, C.1    Graham, W.J.2
  • 5
    • 84901269782 scopus 로고    scopus 로고
    • Global causes of maternal death: a WHO systematic analysis
    • Say, L, Chou, D, Gemmill, A, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health 2 (2014), e323–e333.
    • (2014) Lancet Glob Health , vol.2 , pp. e323-e333
    • Say, L.1    Chou, D.2    Gemmill, A.3
  • 6
    • 85020614697 scopus 로고    scopus 로고
    • Summary of Product Characteristics: Tranexamic acid. (accessed March 3, ).
    • Electronic Medicines Compendium, Summary of Product Characteristics: Tranexamic acid. http://www.medicines.org.uk/emc/medicine/1489 (accessed March 3, 2017).
    • (2017)
  • 7
    • 84861503406 scopus 로고    scopus 로고
    • Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis
    • Ker, K, Edwards, P, Perel, P, Shakur, H, Roberts, I, Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ, 344, 2012, e3054.
    • (2012) BMJ , vol.344 , pp. e3054
    • Ker, K.1    Edwards, P.2    Perel, P.3    Shakur, H.4    Roberts, I.5
  • 8
    • 84881666358 scopus 로고    scopus 로고
    • Systematic review, meta-analysis and meta-regression of the effect of tranexamic acid on surgical blood loss
    • Ker, K, Prieto-Merino, D, Roberts, I, Systematic review, meta-analysis and meta-regression of the effect of tranexamic acid on surgical blood loss. Br J Surg 100 (2013), 1271–1279.
    • (2013) Br J Surg , vol.100 , pp. 1271-1279
    • Ker, K.1    Prieto-Merino, D.2    Roberts, I.3
  • 9
    • 77954717667 scopus 로고    scopus 로고
    • Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial
    • CRASH-2 Collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 376 (2010), 23–32.
    • (2010) Lancet , vol.376 , pp. 23-32
  • 10
    • 79953163189 scopus 로고    scopus 로고
    • The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial
    • CRASH-2 Collaborators. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 377 (2011), 1096–1101.
    • (2011) Lancet , vol.377 , pp. 1096-1101
  • 11
    • 70349868187 scopus 로고    scopus 로고
    • Disseminated intravascular coagulation with a fibrinolytic phenotype at an early phase of trauma predicts mortality
    • Sawamura, A, Hayakawa, M, Gando, S, et al. Disseminated intravascular coagulation with a fibrinolytic phenotype at an early phase of trauma predicts mortality. Thromb Res 124 (2009), 608–613.
    • (2009) Thromb Res , vol.124 , pp. 608-613
    • Sawamura, A.1    Hayakawa, M.2    Gando, S.3
  • 12
    • 84952717613 scopus 로고    scopus 로고
    • Overwhelming tPA release, not PAI-1 degradation, is responsible for hyperfibrinolysis in severely injured trauma patients
    • Chapman, MP, Moore, EE, Moore, HB, et al. Overwhelming tPA release, not PAI-1 degradation, is responsible for hyperfibrinolysis in severely injured trauma patients. J Trauma Acute Care Surg 80 (2016), 16–23.
    • (2016) J Trauma Acute Care Surg , vol.80 , pp. 16-23
    • Chapman, M.P.1    Moore, E.E.2    Moore, H.B.3
  • 14
    • 0023149587 scopus 로고
    • Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors
    • Kruithof, EK, Tran-Thang, C, Gudinchet, A, et al. Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors. Blood 69 (1987), 460–466.
    • (1987) Blood , vol.69 , pp. 460-466
    • Kruithof, E.K.1    Tran-Thang, C.2    Gudinchet, A.3
  • 15
    • 85020561019 scopus 로고    scopus 로고
    • International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Guideline for Good Clinical Practice E6(R1)
    • 1996 June 10. (accessed March 3, ).
    • International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Guideline for Good Clinical Practice E6(R1), 1996 June 10. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6/E6_R2__Step_4.pdf (accessed March 3, 2017).
    • (2017)
  • 16
    • 77952605810 scopus 로고    scopus 로고
    • The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial
    • Shakur, H, Elbourne, D, Gulmezoglu, M, et al. The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial. Trials, 11, 2010, 40.
    • (2010) Trials , vol.11 , pp. 40
    • Shakur, H.1    Elbourne, D.2    Gulmezoglu, M.3
  • 17
    • 84969548845 scopus 로고    scopus 로고
    • The effect of tranexamic acid on the risk of death and hysterectomy in women with post-partum haemorrhage: statistical analysis plan for the WOMAN trial
    • Shakur, H, Roberts, I, Edwards, P, Elbourne, D, Alfirevic, Z, Ronsmans, C, The effect of tranexamic acid on the risk of death and hysterectomy in women with post-partum haemorrhage: statistical analysis plan for the WOMAN trial. Trials, 17, 2016, 249.
    • (2016) Trials , vol.17 , pp. 249
    • Shakur, H.1    Roberts, I.2    Edwards, P.3    Elbourne, D.4    Alfirevic, Z.5    Ronsmans, C.6
  • 18
    • 84888145722 scopus 로고    scopus 로고
    • Dangers of non-specific composite outcome measures in clinical trials
    • Prieto-Merino, D, Smeeth, L, Staa, TP, Roberts, I, Dangers of non-specific composite outcome measures in clinical trials. BMJ, 347, 2013, f6782.
    • (2013) BMJ , vol.347 , pp. f6782
    • Prieto-Merino, D.1    Smeeth, L.2    Staa, T.P.3    Roberts, I.4
  • 19
    • 84942613151 scopus 로고    scopus 로고
    • Factors associated with postpartum hemorrhage maternal death in referral hospitals in Senegal and Mali: a cross-sectional epidemiological survey
    • Tort, J, Rozenberg, P, Traore, M, Fournier, P, Dumont, A, Factors associated with postpartum hemorrhage maternal death in referral hospitals in Senegal and Mali: a cross-sectional epidemiological survey. BMC Pregnancy Childbirth, 15, 2015, 235.
    • (2015) BMC Pregnancy Childbirth , vol.15 , pp. 235
    • Tort, J.1    Rozenberg, P.2    Traore, M.3    Fournier, P.4    Dumont, A.5
  • 20
    • 84929441055 scopus 로고    scopus 로고
    • When getting there is not enough: a nationwide cross-sectional study of 998 maternal deaths and 1451 near-misses in public tertiary hospitals in a low-income country
    • Oladapo, OT, Adetoro, OO, Ekele, BA, et al. When getting there is not enough: a nationwide cross-sectional study of 998 maternal deaths and 1451 near-misses in public tertiary hospitals in a low-income country. BJOG 123 (2016), 928–938.
    • (2016) BJOG , vol.123 , pp. 928-938
    • Oladapo, O.T.1    Adetoro, O.O.2    Ekele, B.A.3
  • 22
    • 85009274687 scopus 로고    scopus 로고
    • Tranexamic acid in patients undergoing coronary-artery surgery
    • Myles, PS, Smith, JA, Forbes, A, et al. Tranexamic acid in patients undergoing coronary-artery surgery. N Engl J Med 376 (2017), 136–148.
    • (2017) N Engl J Med , vol.376 , pp. 136-148
    • Myles, P.S.1    Smith, J.A.2    Forbes, A.3
  • 23
    • 84965111163 scopus 로고    scopus 로고
    • Postpartum haemorrhage related early increase in D-dimers is inhibited by tranexamic acid: haemostasis parameters of a randomized controlled open labelled trial
    • Ducloy-Bouthors, AS, Duhamel, A, Kipnis, E, et al. Postpartum haemorrhage related early increase in D-dimers is inhibited by tranexamic acid: haemostasis parameters of a randomized controlled open labelled trial. Br J Anaesth 116 (2016), 641–648.
    • (2016) Br J Anaesth , vol.116 , pp. 641-648
    • Ducloy-Bouthors, A.S.1    Duhamel, A.2    Kipnis, E.3
  • 24
    • 84862496057 scopus 로고    scopus 로고
    • CRASH-3 - tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial
    • Dewan, Y, Komolafe, EO, Mejia-Mantilla, JH, Perel, P, Roberts, I, Shakur, H, CRASH-3 - tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial. Trials, 13, 2012, 87.
    • (2012) Trials , vol.13 , pp. 87
    • Dewan, Y.1    Komolafe, E.O.2    Mejia-Mantilla, J.H.3    Perel, P.4    Roberts, I.5    Shakur, H.6
  • 25
    • 84934286919 scopus 로고    scopus 로고
    • HALT-IT–tranexamic acid for the treatment of gastrointestinal bleeding: study protocol for a randomised controlled trial
    • Roberts, I, Coats, T, Edwards, P, et al. HALT-IT–tranexamic acid for the treatment of gastrointestinal bleeding: study protocol for a randomised controlled trial. Trials, 15, 2014, 450.
    • (2014) Trials , vol.15 , pp. 450
    • Roberts, I.1    Coats, T.2    Edwards, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.